Protease Stabilized Antibacterial Peptides for S. aureus

Keyphrases

• Protease 100%
• Staphylococcus Aureus 100%
• Antimicrobial Peptides 100%
• Antibacterial Peptide 100%
• Immunogenicity 40%
• Drug Resistance 40%
• Methicillin-resistant Staphylococcus Aureus 40%
• Acute Toxicity 40%
• Arizona State University 20%
• High Specificity 20%
• Biodesign 20%
• Polymer Coating 20%
• Activity Level 20%
• Public Health Risk 20%
• Medical Devices 20%
• High Activity 20%
• Manufacturing Cost 20%
• Proteolytic Degradation 20%
• Antibiotics 20%
• Innate Immune Response 20%
• Multidrug-resistant Pathogens 20%
• Antimicrobial Resistance 20%
• Multidrug-resistant Infection 20%
• Novel Antimicrobials 20%
• Clinical Health 20%
• New Antibiotics 20%
• In Vivo Testing 20%
• New Derivatives 20%
• Degradation-resistant 20%
• Peptide Polymers 20%
• Conventional Antibiotics 20%
• β-lactam Antibiotics 20%
• Separate Components 20%
• Staphylococcal Infections 20%
• Old Antibiotics 20%
• Antibiotic Peptides 20%
• Human Antimicrobial Peptides 20%
• Antibiotic Overuse 20%
• Dual Functionality 20%
• Protease Stability 20%
• Device Implantation 20%
• Topical Cream 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Staphylococcus Aureus 100%
• Proteinase 100%
• Polypeptide Antibiotic Agent 100%
• Antibiotics 57%
• Infectious Agent 28%
• Drug Resistance 28%
• Immunogenicity 28%
• Methicillin-Resistant Staphylococcus Aureus 28%
• Acute Toxicity 28%
• Antimicrobial Resistance 14%
• Bacterial Infection 14%
• Methicillin Susceptible Staphylococcus Aureus 14%
• Staphylococcal Infection 14%
• Beta Lactam Antibiotic 14%
• Antibiotic Peptide 14%
• Diseases 14%